Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
Preclinical markers of neurodegenerative diseases | Download Table
Molecular biomarkers in multiple sclerosis | Journal of Neuroinflammation | Full Text
Frontiers | Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease
Biomarkers of neurodegenerative disorders: How good are they? | Cell Research
Biomarkers for neurodegenerative diseases | Nature Medicine
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Frontiers | Re-thinking the Etiological Framework of Neurodegeneration
Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients | Journal of Neurotrauma
Biomarkers for neurodegenerative diseases | Nature Medicine
The biomarker-based diagnosis of Alzheimer's disease. 2—lessons from oncology - ScienceDirect
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation | Alzheimer's Research & Therapy | Full Text
Empowering Physicians to Advance the Future of Alzheimer's Disease - EMJ
Biomarkers for neurodegenerative diseases | Nature Medicine
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic | Nature Reviews Neurology
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association | Stroke
Biomarkers of neurodegenerative disorders: How good are they? | Cell Research
Biomarkers for neurodegenerative diseases | Nature Medicine
Biomarkers for neurodegenerative diseases | Nature Medicine
Biomarkers for neurodegenerative diseases | Nature Medicine
Testing a blood biomarker for neurodegeneration | National Institute on Aging
Biomarkers for neurodegenerative diseases | Nature Medicine
Neurodegenerative Disease Market Expected to Reach $55.26 bn by 2026
